Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one MeSH Supplementary Concept Data 2026


MeSH Supplementary
1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one
Unique ID
C569670
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C569670
Entry Term(s)
GDC 0980
GDC-0980
GDC0980
Registry Numbers
0
Heading Mapped to
*Pyrimidines
*Bridged Bicyclo Compounds, Heterocyclic
Frequency
35
Note
also inhibits mTOR; structure in first source
Source
J Med Chem. 2011 Nov 10;54(21):7579-87.
Indexing Information
Phosphatidylinositol 3-Kinase
Date Introduced
2012/02/01
Last Updated
2012/02/01
1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one Preferred
GDC 0980 Narrower
page delivered in 0.007s